alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression.
about
Structure of the CaMKIIdelta/calmodulin complex reveals the molecular mechanism of CaMKII kinase activationThe emerging role of CaMKII in cancerNFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiationComputational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer ProgressionTargeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.The multifunctional Ca2+/calmodulin-dependent kinase II delta (CaMKIIdelta) controls neointima formation after carotid ligation and vascular smooth muscle cell proliferation through cell cycle regulation by p21.The growth and aggressive behavior of human osteosarcoma is regulated by a CaMKII-controlled autocrine VEGF signaling mechanismAlpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma.Inactive ERBB receptors cooperate with reactive oxygen species to suppress cancer progression.Kv3.4 potassium channel-mediated electrosignaling controls cell cycle and survival of irradiated leukemia cells.Phosphorylation of calcium/calmodulin-stimulated protein kinase II at T286 enhances invasion and migration of human breast cancer cells.Ca2+/calmodulin-dependent protein kinase II regulates colon cancer proliferation and migration via ERK1/2 and p38 pathways.CaMKII-mediated Beclin 1 phosphorylation regulates autophagy that promotes degradation of Id and neuroblastoma cell differentiationCdk9 T-loop phosphorylation is regulated by the calcium signaling pathway.Fluid shear stress induces osteoblast differentiation and arrests the cell cycle at the G0 phase via the ERK1/2 pathway.
P2860
Q24293502-FA7B3BD9-9F7B-4285-9BA2-BF019457B920Q26995205-BE467C72-5F20-4135-893B-567165A1DA23Q28512313-DC7F33FF-6776-4BB4-A6AA-E12C0B8160B3Q28552533-8B0BEBD3-970B-4B30-A7B2-43B7F1CEF538Q33823577-A68F52DE-C3D8-4253-AA24-93C8AD30FA43Q34624215-AE92A8EF-FEDE-4E06-A275-081BB2C67DB9Q35362682-D1C6FF7D-917E-4736-8543-50AEE4604E85Q36780837-18CB3B79-F55C-47FF-8D95-D4E85E0EA5E8Q37316881-5AF6787D-3B20-484D-B5A7-78E0C83F2A00Q39188078-DAE3F2BA-B03C-45E2-91A6-89F5B60283FAQ41039207-B4C70358-7D29-476B-AD63-98EA0CAEF42FQ42058113-5890A6A7-42A0-45AD-A317-B3D68E523DD1Q42611875-A8DA714C-0F63-4D85-BD80-92D656F7B597Q42847637-86D38401-553A-4932-A4AE-04B67E65F1B2Q47589728-110355E9-2433-4A4F-B9D4-980BD5A00644
P2860
alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 July 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
alpha-CaMKII controls the grow ...... lating cell cycle progression.
@en
alpha-CaMKII controls the grow ...... lating cell cycle progression.
@nl
type
label
alpha-CaMKII controls the grow ...... lating cell cycle progression.
@en
alpha-CaMKII controls the grow ...... lating cell cycle progression.
@nl
prefLabel
alpha-CaMKII controls the grow ...... lating cell cycle progression.
@en
alpha-CaMKII controls the grow ...... lating cell cycle progression.
@nl
P2093
P2860
P1476
alpha-CaMKII controls the grow ...... lating cell cycle progression.
@en
P2093
Kaiyu Yuan
Leland W K Chung
Majd Zayzafoon
P2860
P2888
P304
P356
10.1038/LABINVEST.3700658
P577
2007-07-16T00:00:00Z
P5875
P6179
1015928367